Literature DB >> 35338351

Metabolome and microbiome multi-omics integration from a murine lung inflammation model of bronchopulmonary dysplasia.

Ahmed El Saie1,2, Chenlian Fu3,4, Sandra L Grimm4,5,6, Matthew J Robertson5, Kristi Hoffman7, Vasanta Putluri8, Chandra Shekar R Ambati8, Nagireddy Putluri4,8, Binoy Shivanna1, Cristian Coarfa9,10,11, Mohan Pammi1.   

Abstract

BACKGROUND: Respiratory tract microbial dysbiosis can exacerbate inflammation and conversely inflammation may cause dysbiosis. Dysbiotic microbiome metabolites may lead to bronchopulmonary dysplasia (BPD). Hyperoxia and lipopolysaccharide (LPS) interaction alters lung microbiome and metabolome, mediating BPD lung injury sequence.
METHODS: C57BL6/J mice were exposed to 21% (normoxia) or 70% (hyperoxia) oxygen during postnatal days (PND) 1-14. Pups were injected with LPS (6 mg/kg) or equal PBS volume, intraperitoneally on PND 3, 5, and 7. At PND14, the lungs were collected for microbiome and metabolomic analyses (n = 5/group).
RESULTS: Microbiome alpha and beta diversity were similar between groups. Metabolic changes included hyperoxia 31 up/18 down, LPS 7 up/4 down, exposure interaction 8. Hyperoxia increased Intestinimonas abundance, whereas LPS decreased Clostridiales, Dorea, and Intestinimonas; exposure interaction affected Blautia. Differential co-expression analysis on multi-omics data identified exposure-altered modules. Hyperoxia metabolomics response was integrated with a published matching transcriptome, identifying four induced genes (ALDOA, GAA, NEU1, RENBP), which positively correlated with BPD severity in a published human newborn cohort.
CONCLUSIONS: We report hyperoxia and LPS lung microbiome and metabolome signatures in a clinically relevant BPD model. We identified four genes correlating with BPD status in preterm infants that are promising targets for therapy and prevention. IMPACT: Using multi-omics, we identified and correlated key biomarkers of hyperoxia and LPS on murine lung micro-landscape and examined their potential clinical implication, which shows strong clinical relevance for future research. Using a double-hit model of clinical relevance to bronchopulmonary dysplasia, we are the first to report integrated metabolomic/microbiome landscape changes and identify novel disease biomarker candidates.
© 2022. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Entities:  

Year:  2022        PMID: 35338351      PMCID: PMC9509498          DOI: 10.1038/s41390-022-02002-1

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.953


  40 in total

Review 1.  The new BPD: an arrest of lung development.

Authors:  A J Jobe
Journal:  Pediatr Res       Date:  1999-12       Impact factor: 3.756

Review 2.  The Microbiome and the Respiratory Tract.

Authors:  Robert P Dickson; John R Erb-Downward; Fernando J Martinez; Gary B Huffnagle
Journal:  Annu Rev Physiol       Date:  2015-11-02       Impact factor: 19.318

3.  Summary proceedings from the bronchopulmonary dysplasia group.

Authors:  Michele C Walsh; Stanley Szefler; Jonathan Davis; Marilee Allen; Linda Van Marter; Steve Abman; Lillian Blackmon; Alan Jobe
Journal:  Pediatrics       Date:  2006-03       Impact factor: 7.124

Review 4.  Recent advances in late lung development and the pathogenesis of bronchopulmonary dysplasia.

Authors:  Alicia Madurga; Ivana Mizíková; Jordi Ruiz-Camp; Rory E Morty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-08       Impact factor: 5.464

5.  Long-term pulmonary and cardiovascular morbidities of neonatal hyperoxia exposure in mice.

Authors:  Renuka T Menon; Amrit Kumar Shrestha; Corey L Reynolds; Roberto Barrios; Binoy Shivanna
Journal:  Int J Biochem Cell Biol       Date:  2017-12-07       Impact factor: 5.085

6.  The Lung Microbiota of Healthy Mice Are Highly Variable, Cluster by Environment, and Reflect Variation in Baseline Lung Innate Immunity.

Authors:  Robert P Dickson; John R Erb-Downward; Nicole R Falkowski; Ellen M Hunter; Shanna L Ashley; Gary B Huffnagle
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

Review 7.  Host-microorganism interactions in lung diseases.

Authors:  Benjamin J Marsland; Eva S Gollwitzer
Journal:  Nat Rev Immunol       Date:  2014-12       Impact factor: 53.106

8.  The Airway Microbiome at Birth.

Authors:  Charitharth Vivek Lal; Colm Travers; Zubair H Aghai; Peter Eipers; Tamas Jilling; Brian Halloran; Waldemar A Carlo; Jordan Keeley; Gabriel Rezonzew; Ranjit Kumar; Casey Morrow; Vineet Bhandari; Namasivayam Ambalavanan
Journal:  Sci Rep       Date:  2016-08-04       Impact factor: 4.379

Review 9.  The influence of the microbiome on respiratory health.

Authors:  Tomasz P Wypych; Lakshanie C Wickramasinghe; Benjamin J Marsland
Journal:  Nat Immunol       Date:  2019-09-09       Impact factor: 25.606

10.  The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice.

Authors:  Jeong-Ran Park; Hanbyeol Lee; Seok-In Kim; Se-Ran Yang
Journal:  Oncotarget       Date:  2016-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.